-
公开(公告)号:US12186297B2
公开(公告)日:2025-01-07
申请号:US17394649
申请日:2021-08-05
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
Abstract: Disclosed herein are “ketone body-HMB” or “KB-HMB” compositions including a combination of: (1) hydroxymethyl butyrate; (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) optionally a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such compositions for producing desired physiological effects, such as fat loss, in a mammal. The compositions beneficially enhance fat loss through ketosis while also reducing or eliminating muscle wasting and/or promoting muscle formation.
-
公开(公告)号:US11793778B2
公开(公告)日:2023-10-24
申请号:US17157000
申请日:2021-01-25
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
IPC: A61K31/19 , A61K31/121
CPC classification number: A61K31/19 , A61K31/121 , A23V2200/3322
Abstract: Compositions for delivering ketone bodies to a subject include one or more beta-hydroxybutyrate salts, one or more acetoacetate salts, beta-hydroxybutyric acid, and optionally acetoacetic acid. The compositions may optionally include one or more ketone body esters, such as one or more beta-hydroxybutyrate esters and/or one or more acetoacetate esters. An example composition contains about 2% to about 98% on a molar basis of the one or more beta-hydroxybutyrate salts and the one or more acetoacetate salts, about 2% to about 98% on a molar basis of the beta-hydroxybutyrate free acid and optionally the acetoacetate free acid, and optionally about 2% to about 98% on a molar basis of one or more ketone body esters.
-
公开(公告)号:US11752119B2
公开(公告)日:2023-09-12
申请号:US17384632
申请日:2021-07-23
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Ryan Lowery , Jacob Wilson
CPC classification number: A61K31/19 , A61K9/0053 , A61P31/14
Abstract: In various implementations, beta-hydroxybutyrate may be orally administered to individuals. Administration may allow treatment and/or prevention of respiratory illnesses, in some implementations. Administration may reduce recovery times and improve outcomes in individuals with respiratory illnesses.
-
公开(公告)号:US20220133673A1
公开(公告)日:2022-05-05
申请号:US17555724
申请日:2021-12-20
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
IPC: A61K31/22 , A61K31/19 , A61K9/00 , A61K31/047
Abstract: Compositions and methods for producing elevated blood levels of ketone bodies and modifying metabolic function in a mammal. Compositions include at least one ester of S-beta-hydroxybutyrate and/or a mono- or di-ester of S-1,3-butanediol and at least one ketone body component. The ketone body component includes beta-hydroxybutyrate, acetoacetate, or both. The beta-hydroxybutyrate is R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, or both. When the ketone body component is S-beta-hydroxybutyrate, the 1,3-butanediol is R-1,3-butanediol, S-1,3-butanediol, or both. Compositions may comprise a keto stack of multiple forms of ketone bodies.
-
公开(公告)号:US11129802B2
公开(公告)日:2021-09-28
申请号:US16551570
申请日:2019-08-26
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
Abstract: Disclosed herein are “ketonnabidiol” or “ketannabidiol” compositions including a combination of: (1) cannabidiol (CBD) and/or cannabidiolic acid (CBDA); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketonnabidiol compositions for producing desired physiological effects, such as fat loss, in a mammal. The ketonnabidiol compositions beneficially enhance fat loss through ketosis while also reducing the duration and/or severity of unpleasant “keto flu” symptoms typically associated with ketosis.
-
公开(公告)号:US11033553B2
公开(公告)日:2021-06-15
申请号:US16849901
申请日:2020-04-15
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
IPC: A61K36/258 , A61K31/52 , A61K31/335 , A61K47/46 , A61K31/522 , A23L33/10 , A61K31/198 , A61K31/353 , A23L2/38 , A61K45/06
Abstract: An energy-promoting composition includes a stimulant component such as caffeine, a vasodilator component, an energy source including an exogenous ketone body component, and optionally a nootropic component. The separate components beneficially and synergistically interact with one another enhances the overall energy-promoting effect of the composition more rapidly and to a greater degree than if one or more of the components are omitted. The energy-promoting composition is also formulated to minimize the crash effect common to stimulants such as energy drinks.
-
公开(公告)号:US10980772B2
公开(公告)日:2021-04-20
申请号:US16272328
申请日:2019-02-11
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
Abstract: Disclosed herein are “ketannabis” (or “ketonnabis”) compositions including a combination of: (1) tetrahydrocannabinol (THC); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketannabis compositions for producing desired physiological effects. The ketannabis compositions beneficially enhance the euphoric effects of THC without aggravating common side effects or even acting to reduce common side effects such as anxiety, disruption of short-term memory, appetite increases, heart rate increases, and blood pressure changes.
-
公开(公告)号:US20200061021A1
公开(公告)日:2020-02-27
申请号:US16272328
申请日:2019-02-11
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
Abstract: Disclosed herein are “ketannabis” (or “ketonnabis”) compositions including a combination of: (1) tetrahydrocannabinol (THC); (2) a ketone body component such as beta-hydroxybutyrate (BHB) and/or acetoacetate; and (3) a dietetically or pharmaceutically acceptable carrier. Also disclosed herein are methods of using such ketannabis compositions for producing desired physiological effects. The ketannabis compositions beneficially enhance the euphoric effects of THC without aggravating common side effects or even acting to reduce common side effects such as anxiety, disruption of short-term memory, appetite increases, heart rate increases, and blood pressure changes.
-
9.
公开(公告)号:US20190151267A1
公开(公告)日:2019-05-23
申请号:US16224408
申请日:2018-12-18
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Gary Millet
IPC: A61K31/19 , A61K31/047 , A61K9/00
CPC classification number: A61K31/19 , A61K9/0053 , A61K31/047
Abstract: Ketogenic compositions including a non-racemic mixture of beta-hydroxybutyrate (BHB) enriched with the R-enantiomer are formulated to increase ketone body level in a subject. The non-racemic mixture of BHB is enriched with the R-enantiomer to elevate ketone bodies and increase the rate at which ketosis is achieved yet contains an amount of the S-enantiomer sufficient to provide alternative benefits as discussed herein. In some aspects a composition for increasing ketone body level in a subject contains a dietetically or pharmaceutically acceptable carrier and a non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate, wherein the non-racemic mixture of R-beta-hydroxybutyrate and S-beta-hydroxybutyrate contains from about 55% to 98% by enantiomeric equivalents of the R-beta-hydroxybutyrate and from about 45% to about 2% by enantiomeric equivalents of S-beta-hydroxybutyrate enantiomer.
-
公开(公告)号:US12128020B2
公开(公告)日:2024-10-29
申请号:US18591994
申请日:2024-02-29
Applicant: AXCESS GLOBAL SCIENCES, LLC
Inventor: Ryan Lowery , Jacob Wilson , Terry Lacore
IPC: A61K31/19 , A61K9/00 , A61K31/522 , A61P3/04 , A61P25/28
CPC classification number: A61K31/19 , A61K9/0053 , A61K31/522 , A61P3/04 , A61P25/28
Abstract: In various implementations, beta-hydroxybutyrate, related compounds, and/or one or more other compounds may be administered to an individual to cause weight loss, weight maintenance, elevate blood ketone levels, maintain blood ketone levels, reduce blood glucose levels, maintain blood glucose levels, improve energy, focus, mood, cognitive function, or aide with neurological or inflammatory disorders and/or combinations thereof.
-
-
-
-
-
-
-
-
-